Get complete Patent Opposition Report for Acceleron Pharma

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore Acceleron Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3226887Mar 27, 2024Methods For Treating Myelodysplastic Syndromes And Sideroblastic Anemias1
EP3380121Dec 20, 2023Methods For Treating Eye Disorders1